<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">INI</journal-id>
<journal-id journal-id-type="hwp">spini</journal-id>
<journal-id journal-id-type="nlm-ta">Innate Immun</journal-id>
<journal-title>Innate Immunity</journal-title>
<issn pub-type="ppub">1753-4259</issn>
<issn pub-type="epub">1743-2839</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1753425910393369</article-id>
<article-id pub-id-type="publisher-id">10.1177_1753425910393369</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Down-regulation of NF-κB signalling by polyphenolic compounds prevents endotoxin-induced liver injury in a rat model</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Bharrhan</surname><given-names>Sushma</given-names></name>
<xref ref-type="aff" rid="aff1-1753425910393369">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Chopra</surname><given-names>Kanwaljit</given-names></name>
<xref ref-type="aff" rid="aff2-1753425910393369">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Arora</surname><given-names>Sunil K</given-names></name>
<xref ref-type="aff" rid="aff3-1753425910393369">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Toor</surname><given-names>Jaideep S</given-names></name>
<xref ref-type="aff" rid="aff3-1753425910393369">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Rishi</surname><given-names>Praveen</given-names></name>
<xref ref-type="aff" rid="aff1-1753425910393369">1</xref>
<xref ref-type="corresp" rid="corresp1-1753425910393369"/>
</contrib>
</contrib-group>
<aff id="aff1-1753425910393369"><label>1</label>Department of Microbiology, Basic Medical Sciences Block, Panjab University, Chandigarh, India</aff>
<aff id="aff2-1753425910393369"><label>2</label>University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India</aff>
<aff id="aff3-1753425910393369"><label>3</label>Department of Immunopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India</aff>
<author-notes>
<corresp id="corresp1-1753425910393369">Praveen Rishi PhD, FAMI, Department of Microbiology, Basic Medical Sciences Block, Panjab University, Chandigarh-160014, India. Email: <email>rishipraveen@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>1</issue>
<fpage>70</fpage>
<lpage>79</lpage>
<history>
<date date-type="received"><day>26</day><month>6</month><year>2010</year></date>
<date date-type="rev-recd"><day>16</day><month>10</month><year>2010</year></date>
<date date-type="accepted"><day>11</day><month>11</month><year>2010</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Activation of NF-κB has been reported to play a key role in causing endotoxin-induced hepatic damage through enhanced production of reactive oxygen species and pro-inflammatory mediators. In this context, the potential of polyphenolic phytochemicals in preventing endotoxin-induced liver damage remains unclear. Here, we demonstrate that catechin and quercetin have the potential to down-regulate the initial signalling molecule NF-κB which may further inhibit the downstream cascade including TNF-α and NO. These results were confirmed using <italic>N</italic>-nitro-<sc>L</sc>-arginine methyl ester (L-NAME), the inhibitor of inducible nitric oxide synthase (iNOS) along with the biochemical and histological alterations occurring in the presence and absence of supplementation with both the polyphenols. However, catechin was found to be more effective than quercetin against endotoxin-induced liver injury. These findings suggest that these polyphenols may form a pharmacological basis for designing a therapeutic agent against endotoxin-mediated oxidative damage.</p>
</abstract>
<kwd-group>
<kwd>Endotoxin</kwd>
<kwd>liver injury</kwd>
<kwd>nuclear factor kappa B (NF-κB)</kwd>
<kwd>polyphenols</kwd>
<kwd>tumor necrosis factor alpha (TNF-α)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1753425910393369" sec-type="intro"><title>Introduction</title>
<p>Endotoxin/LPS acts as a potent signalling molecule and is critically involved in the development of a broad spectrum of pathophysiological reactions like fever, hypoxia, intravascular coagulation, tachycardia and tachypnea, ultimately leading to sepsis with consequent multiple organ failure.<sup><xref ref-type="bibr" rid="bibr1-1753425910393369">1</xref>,<xref ref-type="bibr" rid="bibr2-1753425910393369">2</xref></sup> Lipopolysaccharide, a major structural and functional component of the outer membrane of Gram-negative bacteria, is considered the primary inciting mediator of the inflammatory response in the host.<sup><xref ref-type="bibr" rid="bibr3-1753425910393369">3</xref></sup> Lipopolysaccharide binding to host cells induces a receptor-mediated signalling cascade that leads to activation of NF-κB which may happen directly through interleukin-1 receptor-associated kinase (IRAK1) followed by TNF receptor-activated factor 6 (TRAF6), NF-κB inducing kinase (NIK), IκB kinases (IKK), IκB and NF-κB or indirectly through MAPKs including JNK, p38 and ERK pathway. Following activation, NF-κB gets translocated to the nucleus and causes rapid gene induction resulting in the expression of inflammatory mediators, including cytokines (particularly TNF-α and IL-6), chemokines, lipid mediators, inducible nitric oxide synthase (iNOS), enzymes such as cyclooxygenase 2 (COX-2) and adhesion molecules.<sup><xref ref-type="bibr" rid="bibr1-1753425910393369">1</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr3-1753425910393369">3</xref></sup> Tumor necrosis factor-α further stimulates the production of reactive oxygen species (ROS) and reactive nitrogen intermediates (RNIs) by activated cells causing liver damage due to the oxidative stress. Therefore, NF-κB activated directly or indirectly appears to be the key molecule playing a pivotal role in LPS-induced inflammatory responses. In this context, the inhibition of NF-κB by antioxidants may provide a pharmacological basis for manipulating these acute processes.<sup><xref ref-type="bibr" rid="bibr4-1753425910393369">4</xref>,<xref ref-type="bibr" rid="bibr5-1753425910393369">5</xref></sup></p>
<p>Flavonoids are phenolic phytochemicals that represent substantial constituents of the non-energetic part of the human diet and are thought to promote optimal health, partly via their antioxidant effects in protecting cellular components against reactive oxygen species.<sup><xref ref-type="bibr" rid="bibr6-1753425910393369">6</xref></sup> Flavonoids have been reported to be chain-breaking inhibitors of the peroxidation process, scavenging intermediate peroxyl and alkoxyl radicals.<sup><xref ref-type="bibr" rid="bibr7-1753425910393369">7</xref>,<xref ref-type="bibr" rid="bibr8-1753425910393369">8</xref></sup></p>
<p>Amongst these, Quercetin (3,5,7,3′,4′-pentahydroxyflavone) is a widely distributed flavonoid, present in fruit, vegetables, and many other dietary sources.<sup><xref ref-type="bibr" rid="bibr9-1753425910393369">9</xref></sup> This compound has been reported to protect against oxidative stress in various models of tissue injury.<sup><xref ref-type="bibr" rid="bibr10-1753425910393369">10</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr15-1753425910393369">15</xref></sup> <italic>In vitro</italic> studies have shown that quercetin has anti-inflammatory effects regulating nitric oxide, IL-6, and TNF-α release by lipopolysaccharide-stimulated immune cells.<sup><xref ref-type="bibr" rid="bibr16-1753425910393369">16</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr19-1753425910393369">19</xref></sup> Another subclass of the flavonoids is the flavanols, commonly known as green tea catechins.<sup><xref ref-type="bibr" rid="bibr20-1753425910393369">20</xref></sup> Tea polyphenols have been reported to display potent antioxidant, anti-inflammatory, antibacterial, hypocholesterolemic and anticarcinogenic properties.<sup><xref ref-type="bibr" rid="bibr21-1753425910393369">21</xref></sup> Recently, tea polyphenols have been shown to protect against liver injuries including carbon-tetrachloride-induced liver injury and hepatic ischemia-reperfusion injury.<sup><xref ref-type="bibr" rid="bibr22-1753425910393369">22</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr26-1753425910393369">26</xref></sup> However, the effect of these polyphenols on the signalling cascade of free radical generation culminating into oxidative stress-mediated liver damage has not been evaluated. Although, catechin and quercetin have been shown to inhibit NF-κB activation and NO production in cell culture, their effect on LPS-mediated oxidative stress and NF-κB activation in animal models has not been analyzed in detail. The present study, was, therefore, designed to evaluate the potential of catechin and quercetin as natural polyphenolic inhibitors against endotoxin-induced liver injury in a rat model.</p>
</sec>
<sec id="sec2-1753425910393369" sec-type="materials|methods"><title>Materials and methods</title>
<sec id="sec3-1753425910393369"><title>Agents</title>
<p>Lipopolysaccharide (LPS from <italic>Escherichia coli</italic> serotype O111:B4), catechin hydrate and quercetin were obtained from Sigma Aldrich Chemicals (St Louis, MO, USA). The preparations were made fresh every time before the commencement of the experiment. Lipopolysaccharide, dissolved in water for injection, was administered as single intraperitoneal injection. Catechin hydrate and quercetin were dissolved in warm distilled water and administered by oral gavage. <italic>N</italic>-Nitro-<sc>L</sc>-arginine methyl ester (L-NAME), obtained from Sigma Aldrich Chemicals Pvt. Ltd, was used as nitric oxide synthase (NOS) inhibitor. All other chemicals were of analytical grade.</p>
</sec>
<sec id="sec4-1753425910393369"><title>Animals</title>
<p>Female Wistar rats (200–250 g) were procured from Central Animal House, Panjab University, Chandigarh, India. The animals were housed under standard laboratory conditions, maintained on a 12-h light and dark cycle and had free access to food (Ashirwad Industries Pvt Ltd, Punjab, India) and water <italic>ad libitum</italic>. The experimental protocols were approved by the Institutional Animals Ethics Committee of the Panjab University, Chandigarh, and conducted according to the Indian National Science Academy Guidelines for the use and care of experimental animals.</p>
</sec>
<sec id="sec5-1753425910393369"><title>Experimental design</title>
<p>Rats were divided into following groups each comprising of at least 6–8 rats:
<list id="list1-1753425910393369" list-type="order">
<list-item><p><bold>Control group</bold>: rats in this group were administered normal saline,</p></list-item>
<list-item><p><bold>Lipopolysaccharide challenged group</bold>: rats in this group received a dose of LPS (10 mg/kg body weight, pre-standardized dose) i.p.</p></list-item>
<list-item><p><bold>Catechin (CT 50) <italic>per se</italic> group</bold>: animals in this group were supplemented with catechin (50 mg/kg body weight) orally for 15 d.</p></list-item>
<list-item><p><bold>Quercetin (QT 50) <italic>per se</italic> group</bold>: animals in this group were supplemented with quercetin (50 mg/kg body weight) orally for 15 d.</p></list-item>
<list-item><p><bold>Catechin supplemented + LPS challenged group (CT 50 + LPS)</bold>: animals in this group were supplemented with catechin (50 mg/kg body weight) orally for 15 d and then challenged with endotoxin on day 16.</p></list-item>
<list-item><p><bold>Quercetin supplemented + LPS challenged group (QT 50 + LPS)</bold>: animals in this group were supplemented with quercetin (50 mg/kg body weight) orally for 15 d and then challenged with endotoxin on day 16.</p></list-item>
</list>The dose of catechin and quercetin was selected on the basis of preliminary studies done in our laboratory.</p>
<p>Since nitric oxide plays a pivotal role in liver injury, in addition to the above mentioned groups, additional experimental groups were also put up to assess the modulatory effect of catechin and quercetin in the presence of L-NAME (nitric oxide synthase inhibitor) against endotoxin-induced liver injury. Rats were divided into following groups, each consisting of 6–8 rats:
<list id="list2-1753425910393369" list-type="order">
<list-item><p><bold>LPS + Inh</bold>: rats were challenged with a single dose of LPS and after 1 h received a single dose of inhibitor, L-NAME (100 mg/kg body weight, intravenously).</p></list-item>
<list-item><p><bold>CT 50 + LPS + Inh</bold>: rats were supplemented with catechin for 15 d, followed by LPS challenge on day 16, and a single dose of L-NAME after 1 h of LPS challenge.</p></list-item>
<list-item><p><bold>QT 50 + LPS + Inh</bold>: rats were supplemented with quercetin for 15 d, followed by LPS challenge on day 16, and a single dose of L-NAME after 1 h of LPS challenge.</p></list-item>
</list>Animals in all these groups were sacrificed 8 h post-endotoxin challenge by cervical dislocation. Livers were removed quickly, rinsed in cold phosphate buffer saline (0.05 <sc>m</sc>, pH 7.4) and stored at –62°C till further use.</p>
</sec>
<sec id="sec6-1753425910393369"><title>Assessment of liver function</title>
<p>Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) enzyme activities in serum were determined using ERBA test kits (ERBA Diagnostics, Mannheim, Germany). Alkaline phosphatase (ALP) was estimated using Enzopak Diagnostic kit (Reckon Diagnostics, India).</p>
</sec>
<sec id="sec7-1753425910393369"><title>Histological studies</title>
<p>Liver tissues removed aseptically from all the groups were cut into small pieces and fixed in 10% buffered formalin. Samples were processed, stained with hematoxylin-eosin and examined under the light microscope.</p>
</sec>
<sec id="sec8-1753425910393369"><title>Mechanistic studies</title>
<p>Liver removed aseptically from all the groups were rinsed in 0.05 <sc>m</sc> phosphate buffer saline (pH 7.4; PBS). A 25% (w/v) tissue homogenate in each case was prepared in PBS using a Potter–Elvehjen homogenizer. An aliquot of the liver homogenate was used for the estimation of lipid peroxidation and reduced glutathione levels. For the estimation of superoxide dismutase and catalase activities, post mitochondrial preparation was made. For this, the remaining tissue homogenates were centrifuged at 8900 <italic>g</italic> for 20 min at 4°C in a refrigerated centrifuge. The supernatants thus obtained were called ‘post mitochondrial supernatants’ (PMS).</p>
</sec>
<sec id="sec9-1753425910393369"><title>Extent of peroxidative liver damage</title>
<p>The quantitative measurement of lipid peroxidation in liver was performed as described by us earlier.<sup><xref ref-type="bibr" rid="bibr27-1753425910393369">27</xref></sup></p>
</sec>
<sec id="sec10-1753425910393369"><title>Antioxidative enzymes</title>
<p>Superoxide dismutase (SOD) and catalase activities in the liver homogenates were estimated as described earlier.<sup><xref ref-type="bibr" rid="bibr28-1753425910393369">28</xref></sup></p>
</sec>
<sec id="sec11-1753425910393369"><title>Estimation of hepatic nitrite levels</title>
<p>The amount of nitric oxide was determined by Griess reaction, as described by Green et al.<sup><xref ref-type="bibr" rid="bibr29-1753425910393369">29</xref></sup> The assay is based on the propensity of nitric oxide to be oxidized to nitrate and nitrite under physiological conditions. For this, 100 µl aliquots of PMS were mixed with 100 µl of Griess reagent (0.1% naphthylethylene diamine dihydrochloric acid and 1% sulphanilamide in 5% phosphoric acid) and incubated at room temperature (28–30°C) for 10 min. Absorbance was measured at 546 nm. Nitrite levels in all the samples were quantified according to the standard graph of sodium nitrite.</p>
</sec>
<sec id="sec12-1753425910393369"><title>Liver TNF-α assay</title>
<p>Assay for TNF-α was performed by ELISA in the liver homogenate in all the groups by commercially available cytokine assay kit (R&amp;D Systems, USA) according to the manufacturer’s instructions. Briefly, standards for TNF-α were dispensed in the 96-well microtitre plates pre-coated with monoclonal antibody specific for rat TNF-α. To each of the designated wells, 50 µl of each test sample and 50 µl of assay diluent was added, the plates were sealed with acetate plate sealer and incubated at room temperature for 2 h. Plates were then washed five times with the wash buffer and 100 µl of rat TNF-α conjugate was dispensed into each well. Plates were again sealed and incubated at room temperature for 2 h, after which they were washed five times with the wash buffer and 100 µl of substrate solution was dispensed into each well. Plates were finally incubated at room temperature (in dark) for 30 min. Stop solution (100 µl) was added into each well and absorbance was read at 450 nm. The results were expressed as picogram/ml of the TNF-α released. The ELISA was sensitive to 5 picogram/ml of the TNF-α released.</p>
</sec>
<sec id="sec13-1753425910393369"><title>Assay for NF-κB p50 subunit</title>
<p>Assay for NF-κB p50 subunit in the nuclear extracts was performed in all the groups by commercially available Transcription Factor Assay kit (Upstate Biotechnology, NY, USA) according to the manufacturer’s instructions. This assay combines the principle of the electrophoretic mobility shift assay (EMSA) with the 96-well based enzyme linked immunosorbent assay (ELISA). Briefly, nuclear extracts from all the groups were prepared using Chemicon’s Nuclear Extraction Kit. During the assay, the capture probe, a double stranded biotinylated oligonucleotide containing the consensus sequence for NF-κB was mixed with the nuclear extract in the transcription factor assay (TFA) buffer provided directly in the streptavidin coated plate and incubated in plate well for 2 h at room temperature. Plates were then washed to remove the unbound material. The bound NF-κB transcription factor subunit p50 was detected with specific primary antibody, rabbit anti-NF-κB p50. Horse radish peroxidase conjugated secondary antibody was then used for detection using TMB/E (3,3′,5,5′-tetramethybenzidine) as the substrate and absorbance was read at 450 nm. Positive and negative controls were also run simultaneously.</p>
</sec>
<sec id="sec14-1753425910393369"><title>RT-PCR analysis of liver iNOS mRNA expression</title>
<p>Liver tissue of the rats subjected to the indicated treatments were harvested and preserved in RNAlater (Sigma) at –80°C until processing. Total RNA was isolated by using the RNeasy Mini Kit (Qiagen). An equal amount of RNA was then reverse transcribed using the first strand cDNA synthesis kit (Fermentas) and an oligo-d(T) primer. The cDNA obtained was then subjected to PCR using iNOS- and GAPDH-specific primers. GAPDH mRNA was used as an internal control (<xref ref-type="table" rid="table1-1753425910393369">Table 1</xref>).
<table-wrap id="table1-1753425910393369" position="float"><label>Table 1.</label><caption><p>Primers used</p></caption>
<graphic alternate-form-of="table1-1753425910393369" xlink:href="10.1177_1753425910393369-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Primer</th>
<th>Primer sequence</th></tr></thead>
<tbody align="left">
<tr>
<td>Rat iNOS (F)</td>
<td>5′-CTACCTACCTGGGGAACACCTGGG-3′</td></tr>
<tr>
<td>Rat iNOS (R)</td>
<td>5′-GGAGGAGCTGATGGAGTAGTAGCGG-3′</td></tr>
<tr>
<td>GAPDH (F)</td>
<td>5′-TCCCTCAAGATTGTCAGCAA-3′</td></tr>
<tr>
<td>GAPDH (R)</td>
<td>5′-AGATCCACAACGGATACATT-3′</td></tr>
</tbody>
</table>
</table-wrap></p>
</sec>
<sec id="sec15-1753425910393369"><title>Statistical analysis</title>
<p>Results were expressed as mean ± SD. The inter-group variation was measured by one-way analysis of variance (ANOVA) followed by Fisher’s least significant difference test. The statistical analysis was done using Jandel Sigma Stat Statistical Software v2.0. Statistical significance of the results were calculated at least at <italic>P</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="sec16-1753425910393369" sec-type="results"><title>Results</title>
<p>For all the parameters mentioned below, the effect of catechin and quercetin supplementation was assessed at two different doses, <italic>i.e</italic>. 25 and 50 mg/kg body weight. It was found that both the phytochemicals were more effective at a dose of 50 mg/kg body weight as compared to 25 mg/kg body weight (data not shown).</p>
<sec id="sec17-1753425910393369"><title>Clinical chemistry</title>
<p>Challenge with endotoxin caused nearly 2.7-fold rise in serum levels of ALT, 2.4-fold increase in the serum levels of AST and 6-fold increase in the serum ALP levels as compared to the levels in the control group (<italic>P</italic> &lt; 0.05). The activities of liver enzymes were decreased significantly (<italic>P</italic> &lt; 0.05) on supplementation with catechin and quercetin. Catechin and quercetin <italic>per se</italic> had no effect on liver enzyme levels (<xref ref-type="fig" rid="fig1-1753425910393369">Figure 1</xref>).
<fig id="fig1-1753425910393369" position="float"><label>Figure 1.</label><caption><p>Effect of catechin and quercetin on ALT, AST and ALP levels in serum of LPS-challenged rats compared to control groups. Values are expressed as mean ± SD of six different observations. *<italic>P</italic> &lt; 0.05 vs control, catechin and quercetin <italic>per se</italic>; <sup>#</sup><italic>P</italic> &lt; 0.05 vs LPS.</p></caption><graphic xlink:href="10.1177_1753425910393369-fig1.tif"/></fig></p>
</sec>
<sec id="sec18-1753425910393369"><title>Hepatic histo-architecture</title>
<p>Histological evaluation of liver tissues did not reveal any morphological alterations in the control group (<xref ref-type="fig" rid="fig2-1753425910393369">Figure 2</xref>A), catechin (<xref ref-type="fig" rid="fig2-1753425910393369">Figure 2</xref>B) and quercetin <italic>per se</italic> group (<xref ref-type="fig" rid="fig2-1753425910393369">Figure 2</xref>C). In contrast, livers of LPS-challenged rats showed marked morphological disruption such as portal triaditis, Kupffer cell hyperplasia, necrosis and lymphocytic infiltration (<xref ref-type="fig" rid="fig2-1753425910393369">Figure 2</xref>D,E). Supplementation with catechin (<xref ref-type="fig" rid="fig2-1753425910393369">Figure 2</xref>F) and quercetin (<xref ref-type="fig" rid="fig2-1753425910393369">Figure 2</xref>G) resulted in significant morphological protection in terms of marked reduction in inflammation and hepatocyte damage in LPS challenged rats.
<fig id="fig2-1753425910393369" position="float"><label>Figure 2.</label><caption><p>(A) Photomicrograph of the normal/control rat liver showing normal liver morphology. (B) Photomicrograph of rat liver of catechin <italic>per se</italic> group showing normal liver morphology. (C) Photomicrograph of rat liver of quercetin <italic>per se</italic> group showing normal liver morphology. (D,E) Photomicrographs of liver 8 h after LPS challenge to rats showing portal triaditis (portal tract distended with mononuclear cell infiltration) with some breach of lamina limitence indicating development of chronic hepatitis, surrounding liver showing significant Kupffer cell hyperplasia. (F) Photomicrograph of rat livers supplemented with catechin (50 mg/kg) for 15 d before LPS challenge showing mild non-specific changes, but is normal. The portal tracts are intact and hepatocytes are normal. (G) Photomicrograph of rat livers supplemented with quercetin (50 mg/kg) for 15 d before LPS challenge showing mild edema of portal tracts but very little inflammation.</p></caption><graphic xlink:href="10.1177_1753425910393369-fig2.tif"/></fig></p>
</sec>
<sec id="sec19-1753425910393369"><title>Activation of transcription factor NF-κB</title>
<p>Nuclear factor-κB p50 subunit was significantly (<italic>P</italic> &lt; 0.01) elevated in LPS-challenged rats as compared to the control and <italic>per se</italic> groups (<xref ref-type="fig" rid="fig3-1753425910393369">Figure 3</xref>). Supplementation with catechin and quercetin significantly attenuated the activation of NF-κB induced by endotoxin. However, the effect was more pronounced in case of supplementation with catechin. The levels of NF-κB p50 subunit were further reduced significantly (<italic>P</italic> &lt; 0.001) by the administration of L-NAME, the inhibitor of iNOS, to the LPS-challenged groups with or without supplementation.
<fig id="fig3-1753425910393369" position="float"><label>Figure 3.</label><caption><p>Effect of catechin and quercetin on LPS-induced activation of NF-κB in liver. Values are expressed as mean ± SD of five different observations. *<italic>P</italic> &lt; 0.05 vs control, catechin and quercetin <italic>per se</italic>; <sup>#</sup><italic>P</italic> &lt; 0.05 vs LPS; <sup>†</sup><italic>P</italic> &lt; 0.05 vs QT 50 + LPS; <sup>§</sup><italic>P</italic> &lt; 0.05 vs LPS + Inh. Positive control (+control) refers to the TNF-α treated Hela whole cell extract; negative control (–control) refers to the biotinylated double-stranded non-specific competitor oligonucleotide probe which does not contain the NF-κB consensus sequence.</p></caption><graphic xlink:href="10.1177_1753425910393369-fig3.tif"/></fig></p>
</sec>
<sec id="sec20-1753425910393369"><title>Hepatic TNF-α levels</title>
<p>Lipopolysaccharide challenge caused a marked rise in the levels of TNF-α compared to the control group (240.86 ± 20.3 pg/ml vs 119.5 ± 10.2 pg/ml in control). Administration of catechin and quercetin pre-LPS challenge significantly decreased the levels of TNF-α by 1.59- (at <italic>P</italic> &lt; 0.01) and 1.35-fold (at <italic>P</italic> &lt; 0.01), respectively (<xref ref-type="fig" rid="fig4-1753425910393369">Figure 4</xref>). However, catechin showed higher protective effect than quercetin (at <italic>P</italic> &lt; 0.05).
<fig id="fig4-1753425910393369" position="float"><label>Figure 4.</label><caption><p>Effect of catechin and quercetin on hepatic TNF-α levels in LPS-challenged rats. Values are expressed as mean ± SD of four different observations. *<italic>P</italic> &lt; 0.05 vs control, catechin and quercetin <italic>per se</italic>; <sup>#</sup><italic>P</italic> &lt; 0.05 vs LPS; <sup>†</sup><italic>P</italic> &lt; 0.05 vs QT 50 + LPS; <sup>‡</sup><italic>P</italic> &lt; 0.05 vs LPS + Inh.</p></caption><graphic xlink:href="10.1177_1753425910393369-fig4.tif"/></fig></p>
</sec>
<sec id="sec21-1753425910393369"><title>Extent of lipid peroxidation</title>
<p>Lipopolysaccharide caused a significant (<italic>P</italic> &lt; 0.01) 2-fold increase in lipid peroxidation as compared to control rats. However, both catechin and quercetin significantly (<italic>P</italic> &lt; 0.01) attenuated LPS-induced increase in liver MDA levels (<xref ref-type="table" rid="table2-1753425910393369">Table 2</xref>) when rats were supplemented separately with these polyphenols for 15 d before LPS challenge.
<table-wrap id="table2-1753425910393369" position="float"><label>Table 2.</label><caption><p>Modulatory effects of catechin and quercetin on status of oxidative stress and antioxidant defense enzymes in the LPS-challenged rat liver</p></caption>
<graphic alternate-form-of="table2-1753425910393369" xlink:href="10.1177_1753425910393369-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Parameter</th>
<th>LPO (nmoles of MDA/mg protein)</th>
<th>SOD (U/mg protein)</th>
<th>CATALASE (mmoles/mg protein)</th></tr></thead>
<tbody align="left">
<tr>
<td>Control</td>
<td>142.49 ± 18.29</td>
<td>4.37 ± 0.14</td>
<td>39.15 ± 4.15</td></tr>
<tr>
<td>CT 50</td>
<td>147.37 ± 19.5</td>
<td>5.13 ± 0.24</td>
<td>41.47 ± 2.64</td></tr>
<tr>
<td>QT 50</td>
<td>150.89 ± 16.23</td>
<td>4.65 ± 0.35</td>
<td>37.19 ± 3.52</td></tr>
<tr>
<td>LPS</td>
<td>272.36 ± 47.91<xref ref-type="table-fn" rid="table-fn1-1753425910393369">*</xref></td>
<td>1.66 ± 0.16<xref ref-type="table-fn" rid="table-fn1-1753425910393369">*</xref></td>
<td>23.56 ± 2.16<xref ref-type="table-fn" rid="table-fn1-1753425910393369">*</xref></td></tr>
<tr>
<td>CT 50 + LPS</td>
<td>173.24 ± 35.18<sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">#</xref></sup></td>
<td>4.15 ± 0.07<xref ref-type="table-fn" rid="table-fn1-1753425910393369">*</xref><sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">#</xref></sup><sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">†</xref></sup></td>
<td>36.97 ± 1.96<sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">#</xref></sup></td></tr>
<tr>
<td>QT 50 + LPS</td>
<td>181.44 ± 30.31<sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">#</xref></sup></td>
<td>3.68 ± 0.09<xref ref-type="table-fn" rid="table-fn1-1753425910393369">*</xref><sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">#</xref></sup></td>
<td>32.08 ± 2.35<xref ref-type="table-fn" rid="table-fn1-1753425910393369">*</xref><sup><xref ref-type="table-fn" rid="table-fn1-1753425910393369">#</xref></sup></td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1753425910393369">
<p>Values are expressed as mean ± SD of six different observations. *<italic>P</italic> &lt; 0.01 vs control, catechin and quercetin <italic>per se</italic>; <sup>#</sup><italic>P</italic> &lt; 0.01 vs LPS; <sup>†</sup><italic>P</italic> &lt; 0.01 vs QT 50 + LPS.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec22-1753425910393369"><title>Hepatic antioxidative enzymes</title>
<p>Lipopolysaccharide significantly reduced the levels of liver SOD and catalase as compared to the control group (2.6- and 1.7-fold, respectively). Supplementation with catechin and quercetin increased the SOD levels in LPS challenged groups by 2.5- and 2.2-fold, respectively, at <italic>P</italic> &lt; 0.01. However, the increase in SOD activity was more pronounced in case of catechin supplementation than quercetin (<italic>P</italic> &lt; 0.01). Catalase activity was also significantly increased at <italic>P</italic> &lt; 0.01 in LPS challenged groups which were supplemented with catechin and quercetin by 1.57- and 1.36-fold, respectively (<xref ref-type="table" rid="table2-1753425910393369">Table 2</xref>). <italic>Per se</italic> groups did not show any significant change in the antioxidant enzyme levels.</p>
</sec>
<sec id="sec23-1753425910393369"><title>Hepatic nitrite levels</title>
<p>Nitrite levels in the liver homogenates were found to be significantly higher in LPS challenged groups as compared to the control counterpart (13.43 ± 2.08 µmol/mg protein and 3.55 ± 0.71 µmol/mg protein, respectively). Supplementation with polyphenols significantly decreased the hepatic nitrite levels (<italic>P</italic> &lt; 0.05). Catechin was found to be more effective than quercetin in inhibiting the LPS-induced increase in nitrite levels (<italic>P</italic> &lt; 0.05). It was also observed that LPS-induced rise in nitrite level was further significantly decreased in  the presence of inhibitor, L-NAME (<italic>P</italic> &lt; 0.05) in both supplemented and non-supplemented groups (<xref ref-type="fig" rid="fig5-1753425910393369">Figure 5</xref>). <italic>Per se</italic> groups did not show any effect.
<fig id="fig5-1753425910393369" position="float"><label>Figure 5.</label><caption><p>Estimation of hepatic nitrite levels of different experimental groups. Values are expressed as mean ± SD of six different observations. *<italic>P</italic> &lt; 0.05 vs. control, catechin and quercetin <italic>per se</italic>; <sup>#</sup><italic>P</italic> &lt; 0.05 vs LPS; <sup>†</sup><italic>P</italic> &lt; 0.05 vs QT 50 + LPS; <sup>§</sup><italic>P</italic> &lt; 0.05 vs LPS + Inh.</p></caption><graphic xlink:href="10.1177_1753425910393369-fig5.tif"/></fig></p>
</sec>
<sec id="sec24-1753425910393369"><title>Hepatic iNOS expression</title>
<p>As observed from <xref ref-type="fig" rid="fig6-1753425910393369">Figure 6</xref>, mRNA expression levels encoding GAPDH were identical in all the groups. In contrast, iNOS mRNA was strongly expressed in LPS-challenged tissue compared with the control tissue. Densitometric analysis of PCR bands showed nearly 20% inhibition of the expression of iNOS mRNA after the administration of iNOS inhibitor in comparison to the LPS-challenged group. However, no significant reduction was observed with the polyphenols used.
<fig id="fig6-1753425910393369" position="float"><label>Figure 6.</label><caption><p>RT-PCR showing expression of iNOS in different experimental groups. Total RNA was isolated by using the RNeasy Mini Kit (Qiagen) from liver tissues of the rats subjected to the indicated treatments. RNA was then reverse transcribed and subjected to PCR using iNOS- and GAPDH-specific primers. GAPDH mRNA was used as an internal control.</p></caption><graphic xlink:href="10.1177_1753425910393369-fig6.tif"/></fig></p>
</sec>
</sec>
<sec id="sec25-1753425910393369" sec-type="discussion"><title>Discussion</title>
<p>Nuclear factor-κB is functional as hetero- or homo-dimeric form of proteins in the Rel family, such as RelA (p65), RelB, cRel, p50 and p52.<sup><xref ref-type="bibr" rid="bibr30-1753425910393369">30</xref>,<xref ref-type="bibr" rid="bibr31-1753425910393369">31</xref></sup> Under normal conditions, NF-κB is sequestered in the cytoplasm as an inactive complex, bound to the inhibitory κB (IκB) proteins. Following any kind of stress/insult, IκB phosphorylated by IKK undergoes degradation.<sup><xref ref-type="bibr" rid="bibr32-1753425910393369">32</xref></sup> The liberated NF-κB translocates to the nucleus, binds to a 10 base pair (bp) consensus sequence (κB) in the promoter region of target genes, thereby allowing rapid gene induction and the expression of inflammatory mediators, including cytokines (particularly TNF-α and IL-6), chemokines, lipid mediators, inducible nitric oxide synthase (iNOS), enzymes and adhesion molecules.<sup><xref ref-type="bibr" rid="bibr33-1753425910393369">33</xref>,<xref ref-type="bibr" rid="bibr34-1753425910393369">34</xref></sup> Thus, NF-κB plays a key role during inflammation and proliferation.</p>
<p>In the present study, we observed that both catechin and quercetin inhibited the activation of NF-κB in LPS challenged rat livers which might have suppressed the liver injury (<xref ref-type="fig" rid="fig1-1753425910393369">Figs 1</xref> and <xref ref-type="fig" rid="fig2-1753425910393369">2</xref>). This observation is consistent with previous reports wherein green tea polyphenols and quercetin have been shown to inhibit NF-κB activation in ischemia-reperfusion liver injury<sup><xref ref-type="bibr" rid="bibr35-1753425910393369">35</xref></sup> and streptozotocin-diabetic rats,<sup><xref ref-type="bibr" rid="bibr14-1753425910393369">14</xref></sup> respectively. These polyphenols might have induced suppression of the release of NF-κB by preventing the degradation of IκBα.<sup><xref ref-type="bibr" rid="bibr14-1753425910393369">14</xref></sup> Blocking of NF-κB activation may further down regulate TNF-α, as has been reported earlier.<sup><xref ref-type="bibr" rid="bibr36-1753425910393369">36</xref></sup> In the present study also, catechin and quercetin significantly decreased the levels of TNF-α in LPS challenged animals. Decreased levels of TNF-α may thus be attributed to the anti-inflammatory mechanism of these polyphenolic compounds. In agreement with the present data, Yang and colleagues<sup><xref ref-type="bibr" rid="bibr37-1753425910393369">37</xref></sup> have shown that green tea polyphenol, epigallocatechin gallate inhibits LPS-induced TNF-α gene and protein production in mouse macrophage cell line. Cellular sensitivity or resistance to TNF-α is also correlated with decreased or increased levels of SOD, respectively.<sup><xref ref-type="bibr" rid="bibr27-1753425910393369">27</xref>,<xref ref-type="bibr" rid="bibr38-1753425910393369">38</xref></sup> In the present study also, increased levels of TNF-α after LPS injection correlated with the increased level of peroxidation and decreased activities of SOD and catalase. In the absence of an appropriate compensatory response from the endogenous antioxidant network, the system may become overwhelmed (redox imbalance), leading to the activation of stress-sensitive signalling pathways, such as NF-κB, and others. Furthermore, polyphenols attenuated the rise of liver malondialdehyde levels, increased the levels of hepatic antioxidants after LPS-challenge, and the liver injury was ameliorated (<xref ref-type="table" rid="table2-1753425910393369">Table 2</xref>). These effects might have been due to the antioxidative property of these polyphenols in the supplemented rats. It has been suggested that flavonoids such as quercetin and catechin could localize near the membrane surface, trapping directly any radical generated in the lipid environment of the membranes as well as ROS generated in the aqueous phase.<sup><xref ref-type="bibr" rid="bibr39-1753425910393369">39</xref></sup> This might block the superoxide radical in the tissues and decrease SOD consumption thus enhancing SOD activity.</p>
<p>One major consequence of the activation of stress-sensitive signalling pathways is the generation of gene products such as nitric oxide that cause cellular damage. In the liver, it is produced by at least two different isoforms of NOS, <italic>e.g</italic>. eNOS and iNOS. The eNOS is constitutively expressed and generates relatively small amounts of NO, but plays an important role in vasorelaxation.<sup><xref ref-type="bibr" rid="bibr40-1753425910393369">40</xref></sup> Overproduction of NO following acute endotoxemia is known to be mediated by increased iNOS expression.<sup><xref ref-type="bibr" rid="bibr41-1753425910393369">41</xref></sup> Nitric oxide in conjunction with superoxide radical has been reported to form a potent and versatile oxidant peroxynitrite, which may lead to the stimulation of TNF-α production in Kupffer cells.<sup><xref ref-type="bibr" rid="bibr42-1753425910393369">42</xref></sup> Enhanced expression of iNOS and hence increased NO levels observed in the endotoxin-challenged animals might have been associated with TNF-α as it is known for its potent stimulatory activity of iNOS which increases the NO levels.<sup><xref ref-type="bibr" rid="bibr43-1753425910393369">43</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr45-1753425910393369">45</xref></sup> The present study showed that catechin and quercetin significantly inhibited the LPS-induced increased hepatic nitrite levels, thus correlating well with the decreased TNF-α levels indicating an interplay of these molecules in determining the outcome of a clinical manifestation.</p>
<p>Inhibition of NF-κB activation is considered to be important when designing iNOS inhibitors because NF-κB activation is the primary regulatory step involved in iNOS expression.<sup><xref ref-type="bibr" rid="bibr46-1753425910393369">46</xref></sup> It was observed that administration of L-NAME not only decreased the expression of liver iNOS thereby resulting in decreased hepatic nitrite levels but also suppressed the LPS-induced activation of NF-κB which also highlights the role of NO in the injury. The effect was more pronounced in case where flavonoids were supplemented before LPS challenge. Therefore, in this model also, inhibition of nitric oxide is presumably associated with the hepatoprotective effect of catechin and quercetin. In support of our findings, <italic>in vitro</italic> studies have shown that green tea polyphenol, EGCG and quercetin decreases LPS-induced iNOS expression and activity in murine peritoneal macrophages via preventing NF-κB activation.<sup><xref ref-type="bibr" rid="bibr47-1753425910393369">47</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr49-1753425910393369">49</xref></sup> It is also indicated from the present study that these polyphenols may not be directly inhibiting the iNOS expression at the transcription level. However, a decrease in nitrite levels might be due to the inhibition of NF-κB induced by the compounds.</p>
</sec>
<sec id="sec26-1753425910393369" sec-type="conclusions"><title>Conclusions</title>
<p>Both catechin and quercetin have the potential to attenuate endotoxin-induced liver injury by down-regulating NF-κB activation and further going downstream the signalling cascade including TNF-α, NO and ROS and by enhancing the antioxidant profile of the challenged host. However, catechin was found to be more effective than quercetin against endotoxin-induced liver injury. Our findings suggest that polyphenols may block the production of noxious mediators involved in liver injury by targeting the IKK/NF-κB signal transduction pathway and therefore, may be of importance in making strategies for management of the disease.</p>
</sec>
</body>
<back><ack>
<title>Acknowledgement</title>
<p>The authors are grateful to the Indian Council of Medical Research (ICMR), New Delhi, India, for providing financial assistance to carry out this research work.</p></ack>
<ref-list>
<title>References</title>
<ref id="bibr1-1753425910393369"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cadenas</surname><given-names>S</given-names></name><name><surname>Cadenas</surname><given-names>AM</given-names></name></person-group>. <article-title>Fighting the stranger-antioxidant protection against endotoxin toxicity</article-title>. <source>Toxicology</source> <year>2002</year>; <volume>180</volume>: <fpage>45</fpage>–<lpage>63</lpage>.</citation></ref>
<ref id="bibr2-1753425910393369"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Victor</surname><given-names>VM</given-names></name><name><surname>Rocha</surname><given-names>M</given-names></name><name><surname>Esplugues</surname><given-names>JV</given-names></name><name><surname>De la Fuente</surname><given-names>M</given-names></name></person-group>. <article-title>Role of free radicals in sepsis: antioxidant therapy</article-title>. <source>Curr Pharm Design</source> <year>2005</year>; <volume>11</volume>: <fpage>3141</fpage>–<lpage>3158</lpage>.</citation></ref>
<ref id="bibr3-1753425910393369"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Victor</surname><given-names>VM</given-names></name><name><surname>Rocha</surname><given-names>M</given-names></name><name><surname>De la Fuente</surname><given-names>M</given-names></name></person-group>. <article-title>Immune cells: free radicals and antioxidants in sepsis</article-title>. <source>Int Immunopharmacol</source> <year>2004</year>; <volume>4</volume>: <fpage>327</fpage>–<lpage>347</lpage>.</citation></ref>
<ref id="bibr4-1753425910393369"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Victor</surname><given-names>VM</given-names></name><name><surname>Minano</surname><given-names>M</given-names></name><name><surname>Guayerbas</surname><given-names>N</given-names></name><name><surname>Del Rio</surname><given-names>M</given-names></name><name><surname>Medina</surname><given-names>S</given-names></name><name><surname>De la Fuente</surname><given-names>M</given-names></name></person-group>. <article-title>Effects of endotoxic shock in several functions of murine peritoneal macrophages</article-title>. <source>Mol Cell Biochem</source> <year>1998</year>; <volume>189</volume>: <fpage>25</fpage>–<lpage>31</lpage>.</citation></ref>
<ref id="bibr5-1753425910393369"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Victor</surname><given-names>VM</given-names></name><name><surname>De la Fuente</surname><given-names>M</given-names></name></person-group>. <article-title>Changes in the superoxide production and other macrophage functions could be related to the mortality of mice with endotoxin-induced oxidative stress</article-title>. <source>Physiol Res</source> <year>2003</year>; <volume>52</volume>: <fpage>101</fpage>–<lpage>110</lpage>.</citation></ref>
<ref id="bibr6-1753425910393369"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hertog</surname><given-names>MGL</given-names></name><name><surname>Hollman</surname><given-names>PCH</given-names></name></person-group>. <article-title>Potential health effects of the dietary flavonol quercetin</article-title>. <source>Eur J Clin Nutr</source> <year>1996</year>; <volume>50</volume>: <fpage>63</fpage>–<lpage>71</lpage>.</citation></ref>
<ref id="bibr7-1753425910393369"><label>7</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Jovanovic</surname><given-names>SV</given-names></name><name><surname>Steenken</surname><given-names>S</given-names></name><name><surname>Simic</surname><given-names>MG</given-names></name><name><surname>Hara</surname><given-names>Y</given-names></name></person-group>. <article-title>Antioxidant properties of flavonoids: reduction potentials and electron transfer reactions of flavonoid radicals</article-title>. In: <person-group person-group-type="editor"><name><surname>Rice-Evans</surname><given-names>C</given-names></name><name><surname>Packer</surname><given-names>L</given-names></name></person-group> (eds) <source>Flavonoids in health and disease</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Marcel Dekker</publisher-name>, <year>1998</year>, pp. <fpage>137</fpage>–<lpage>161</lpage>.</citation></ref>
<ref id="bibr8-1753425910393369"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rice-Evans</surname><given-names>C</given-names></name></person-group>. <article-title>Flavonoid antioxidants</article-title>. <source>Curr Med Chem</source> <year>2001</year>; <volume>8</volume>: <fpage>797</fpage>–<lpage>807</lpage>.</citation></ref>
<ref id="bibr9-1753425910393369"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>L</given-names></name></person-group>. <article-title>Polyphenols: chemistry, dietary sources, metabolism and nutritional significance</article-title>. <source>Nutr Rev</source> <year>1998</year>; <volume>56</volume>: <fpage>317</fpage>–<lpage>333</lpage>.</citation></ref>
<ref id="bibr10-1753425910393369"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huk</surname><given-names>I</given-names></name><name><surname>Brovkovich</surname><given-names>V</given-names></name><name><surname>Nanobash</surname><given-names>V</given-names></name><name><surname>Weigel</surname><given-names>G</given-names></name><name><surname>Neumayer</surname><given-names>C</given-names></name><name><surname>Partyka</surname><given-names>L</given-names></name></person-group>. <article-title>Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischemia-reperfusion injury: an experimental study</article-title>. <source>Br J Surg</source> <year>1998</year>; <volume>85</volume>: <fpage>1080</fpage>–<lpage>1085</lpage>.</citation></ref>
<ref id="bibr11-1753425910393369"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duarte</surname><given-names>J</given-names></name><name><surname>Galisteo</surname><given-names>M</given-names></name><name><surname>Ocete</surname><given-names>MA</given-names></name><name><surname>Perez-Vizcaino</surname><given-names>F</given-names></name><name><surname>Zarzuelo</surname><given-names>A</given-names></name><name><surname>Tamargo</surname><given-names>J</given-names></name></person-group>. <article-title>Effect of chronic quercetin treatment on hepatic oxidative status in spontaneously hypersensitive rats</article-title>. <source>Mol Cell Biochem</source> <year>2001</year>; <volume>221</volume>: <fpage>155</fpage>–<lpage>160</lpage>.</citation></ref>
<ref id="bibr12-1753425910393369"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peres</surname><given-names>W</given-names></name><name><surname>Tunon</surname><given-names>MJ</given-names></name><name><surname>Mato</surname><given-names>S</given-names></name><name><surname>Collado</surname><given-names>PS</given-names></name><name><surname>Marroni</surname><given-names>N</given-names></name><name><surname>Gonzalez-Gallego</surname><given-names>J</given-names></name></person-group>. <article-title>Hepatoprotective effects of the flavonoid quercetin in rats with biliary obstruction</article-title>. <source>J Hepatol</source> <year>2000</year>; <volume>33</volume>: <fpage>742</fpage>–<lpage>750</lpage>.</citation></ref>
<ref id="bibr13-1753425910393369"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wadsworth</surname><given-names>TL</given-names></name><name><surname>Koop</surname><given-names>DR</given-names></name></person-group>. <article-title>Effects of <italic>Gingko biloba</italic> extract (Egb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide</article-title>. <source>Chem Biol Interact</source> <year>2001</year>; <volume>137</volume>: <fpage>43</fpage>–<lpage>58</lpage>.</citation></ref>
<ref id="bibr14-1753425910393369"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>AS</given-names></name><name><surname>Porawski</surname><given-names>M</given-names></name><name><surname>Alonso</surname><given-names>M</given-names></name><name><surname>Marroni</surname><given-names>N</given-names></name><name><surname>Collado</surname><given-names>PS</given-names></name><name><surname>Gonzalez-Gallego</surname><given-names>J</given-names></name></person-group>. <article-title>Quercetin decreases oxidative stress, NF-κB activation and iNOS overexpression in liver of streptozotocin-induced diabetic rats</article-title>. <source>J Nutr</source> <year>2005</year>; <volume>135</volume>: <fpage>2299</fpage>–<lpage>2304</lpage>.</citation></ref>
<ref id="bibr15-1753425910393369"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tieppo</surname><given-names>J</given-names></name><name><surname>Cuevas</surname><given-names>MJ</given-names></name><name><surname>Vercelino</surname><given-names>R</given-names></name><name><surname>Tunon</surname><given-names>MJ</given-names></name><name><surname>Marroni</surname><given-names>NP</given-names></name><name><surname>Gonzalez-Gallego</surname><given-names>J</given-names></name></person-group>. <article-title>Quercetin administration ameliorates pulmonary complications of cirrhosis in rats</article-title>. <source>J Nutr</source> <year>2009</year>; <volume>139</volume>: <fpage>1339</fpage>–<lpage>1346</lpage>.</citation></ref>
<ref id="bibr16-1753425910393369"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manjeet</surname><given-names>KR</given-names></name><name><surname>Ghosh</surname><given-names>B</given-names></name></person-group>. <article-title>Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-alpha production in murine macrophages</article-title>. <source>Int J Immunopharmacol</source> <year>1999</year>; <volume>21</volume>: <fpage>435</fpage>–<lpage>443</lpage>.</citation></ref>
<ref id="bibr17-1753425910393369"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>Y</given-names></name></person-group>. <article-title>The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils</article-title>. <source>Cell Mol Immunol</source> <year>2005</year>; <volume>2</volume>: <fpage>455</fpage>–<lpage>460</lpage>.</citation></ref>
<ref id="bibr18-1753425910393369"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BH</given-names></name><name><surname>Lee</surname><given-names>IJ</given-names></name><name><surname>Lee</surname><given-names>HY</given-names></name><etal/></person-group>. <article-title>Quercetin 3-O-beta-(20-galloyl)-glucopyranoside inhibits endotoxin LPS-induced IL-6 expression and NF-kappa B activation in macrophages</article-title>. <source>Cytokine</source> <year>2007</year>; <volume>39</volume>: <fpage>207</fpage>–<lpage>215</lpage>.</citation></ref>
<ref id="bibr19-1753425910393369"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okoko</surname><given-names>T</given-names></name><name><surname>Oruambo</surname><given-names>IF</given-names></name></person-group>. <article-title>Inhibitory activity of quercetin and its metabolite on lipopolysaccharide-induced activation of macrophage U937 cells</article-title>. <source>Food Chem Toxicol</source> <year>2009</year>; <volume>47</volume>: <fpage>809</fpage>–<lpage>812</lpage>.</citation></ref>
<ref id="bibr20-1753425910393369"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rice-Evans</surname><given-names>C</given-names></name><name><surname>Miller</surname><given-names>NJ</given-names></name><name><surname>Paganga</surname><given-names>G</given-names></name></person-group>. <article-title>Structure-antioxidant activity relationships of flavonoids and phenolic acids</article-title>. <source>Free Radic Biol Med</source> <year>1996</year>; <volume>20</volume>: <fpage>933</fpage>–<lpage>956</lpage>.</citation></ref>
<ref id="bibr21-1753425910393369"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Provan</surname><given-names>GJ</given-names></name><name><surname>Helliwell</surname><given-names>K</given-names></name></person-group>. <article-title>Tea flavonoids: their functions, utilization and analysis</article-title>. <source>Trends Food Sci Technol</source> <year>2000</year>; <volume>11</volume>: <fpage>152</fpage>–<lpage>160</lpage>.</citation></ref>
<ref id="bibr22-1753425910393369"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JH</given-names></name><name><surname>Tipoe</surname><given-names>GL</given-names></name><name><surname>Liong</surname><given-names>EC</given-names></name><etal/></person-group>. <article-title>Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants</article-title>. <source>Am J Clin Nutr</source> <year>2004</year>; <volume>80</volume>: <fpage>742</fpage>–<lpage>751</lpage>.</citation></ref>
<ref id="bibr23-1753425910393369"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhen</surname><given-names>MC</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>XH</given-names></name><etal/></person-group>. <article-title>Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon-tetrachloride-induced hepatic fibrosis</article-title>. <source>J Nutr Biochem</source> <year>2007</year>; <volume>18</volume>: <fpage>795</fpage>–<lpage>805</lpage>.</citation></ref>
<ref id="bibr24-1753425910393369"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Froh</surname><given-names>M</given-names></name><name><surname>Lehnert</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Polyphenols from <italic>Camellia sinensis</italic> attenuate experimental cholestasis-induced liver fibrosis in rats</article-title>. <source>Am J Physiol</source> <year>2003</year>; <volume>285</volume>: <fpage>G1004</fpage>–<lpage>G1013</lpage>.</citation></ref>
<ref id="bibr25-1753425910393369"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>GJ</given-names></name><name><surname>Gong</surname><given-names>ZJ</given-names></name><name><surname>Sun</surname><given-names>XM</given-names></name><name><surname>Zheng</surname><given-names>SH</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Tea polyphenols inhibit expressions of iNOS and TNF-α and prevent lipopolysaccharide-induced liver injury in rats</article-title>. <source>Hepatobiliary Pancreat Dis Int</source> <year>2006</year>; <volume>5</volume>: <fpage>262</fpage>–<lpage>267</lpage>.</citation></ref>
<ref id="bibr26-1753425910393369"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giakoustidis</surname><given-names>A</given-names></name><name><surname>Giakoustidis</surname><given-names>DE</given-names></name><name><surname>Iliadis</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Attenuation of intestinal ischemia/reperfusion-induced liver and lung injury by intraperitoneal administration of (–)-epigallocatechin-3-gallate</article-title>. <source>Free Radic Res</source> <year>2006</year>; <volume>40</volume>: <fpage>103</fpage>–<lpage>110</lpage>.</citation></ref>
<ref id="bibr27-1753425910393369"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chanana</surname><given-names>V</given-names></name><name><surname>Majumdar</surname><given-names>S</given-names></name><name><surname>Rishi</surname><given-names>P</given-names></name></person-group>. <article-title>Involvement of caspase-3, lipid peroxidation and TNF-alpha in causing apoptosis of macrophages by coordinately expressed Salmonella phenotype under stress conditions</article-title>. <source>Mol Immunol</source> <year>2007</year>; <volume>44</volume>: <fpage>1551</fpage>–<lpage>1558</lpage>.</citation></ref>
<ref id="bibr28-1753425910393369"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rishi</surname><given-names>P</given-names></name><name><surname>Kaur</surname><given-names>H</given-names></name><name><surname>Tirkey</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Are the increases in local tumour necrosis factor and lipid peroxidation observed in pre-starved mice infected with <italic>Salmonella typhimurium</italic> markers of increased liver damage?</article-title>. <source>Microbes Infect</source> <year>2006</year>; <volume>8</volume>: <fpage>1695</fpage>–<lpage>1701</lpage>.</citation></ref>
<ref id="bibr29-1753425910393369"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>LC</given-names></name><name><surname>Wagner</surname><given-names>DA</given-names></name><name><surname>Glogowski</surname><given-names>J</given-names></name><name><surname>Shipper</surname><given-names>PL</given-names></name><name><surname>Wishnok</surname><given-names>JS</given-names></name><name><surname>Tannenbaum</surname><given-names>SR</given-names></name></person-group>. <article-title>Analysis of nitrate, nitrite and <sup>15</sup>N nitrate in biological fluids</article-title>. <source>Anal Biochem</source> <year>1982</year>; <volume>126</volume>: <fpage>131</fpage>–<lpage>138</lpage>.</citation></ref>
<ref id="bibr30-1753425910393369"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baeuerle</surname><given-names>PA</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group>. <article-title>NF-κB: ten years after</article-title>. <source>Cell</source> <year>1996</year>; <volume>87</volume>: <fpage>13</fpage>–<lpage>20</lpage>.</citation></ref>
<ref id="bibr31-1753425910393369"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>May</surname><given-names>MJ</given-names></name><name><surname>Kopp</surname><given-names>EB</given-names></name></person-group>. <article-title>NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses</article-title>. <source>Annu Rev Immunol</source> <year>1998</year>; <volume>16</volume>: <fpage>225</fpage>–<lpage>260</lpage>.</citation></ref>
<ref id="bibr32-1753425910393369"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stancovski</surname><given-names>I</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group>. <article-title>NF-κB activation: the IκB kinase revealed?</article-title>. <source>Cell</source> <year>1997</year>; <volume>91</volume>: <fpage>299</fpage>–<lpage>302</lpage>.</citation></ref>
<ref id="bibr33-1753425910393369"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guha</surname><given-names>M</given-names></name><name><surname>Mackman</surname><given-names>N</given-names></name></person-group>. <article-title>LPS induction of gene expression in human monocytes</article-title>. <source>Cell Signal</source> <year>2001</year>; <volume>13</volume>: <fpage>85</fpage>–<lpage>94</lpage>.</citation></ref>
<ref id="bibr34-1753425910393369"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>B</given-names></name><name><surname>Brasier</surname><given-names>AR</given-names></name></person-group>. <article-title>Identification of a nuclear factor κB-dependent gene network</article-title>. <source>Recent Prog Horm Res</source> <year>2003</year>; <volume>58</volume>: <fpage>95</fpage>–<lpage>130</lpage>.</citation></ref>
<ref id="bibr35-1753425910393369"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>Z</given-names></name><name><surname>Froh</surname><given-names>M</given-names></name><name><surname>Connor</surname><given-names>HD</given-names></name><etal/></person-group>. <article-title>Prevention of hepatic ischemia-reperfusion injury by green tea extract</article-title>. <source>Am J Physiol</source> <year>2002</year>; <volume>283</volume>: <fpage>G957</fpage>–<lpage>G964</lpage>.</citation></ref>
<ref id="bibr36-1753425910393369"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>GL</given-names></name></person-group>. <article-title>Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation</article-title>. <source>Am J Physiol</source> <year>2002</year>; <volume>283</volume>: <fpage>G256</fpage>–<lpage>G265</lpage>.</citation></ref>
<ref id="bibr37-1753425910393369"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Villiers</surname><given-names>WJS</given-names></name><name><surname>McClain</surname><given-names>C</given-names></name><name><surname>Varilek</surname><given-names>GW</given-names></name></person-group>. <article-title>Green tea polyphenols block endotoxin-induced tumor necrosis factor production and lethality in a murine model</article-title>. <source>J Nutr</source> <year>1998</year>; <volume>128</volume>: <fpage>2334</fpage>–<lpage>2340</lpage>.</citation></ref>
<ref id="bibr38-1753425910393369"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>K</given-names></name><name><surname>Longo</surname><given-names>DL</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name></person-group>. <article-title>Over expression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anti cancer drugs, and ionizing radiation</article-title>. <source>FASEB J</source> <year>1993</year>; <volume>7</volume>: <fpage>361</fpage>–<lpage>368</lpage>.</citation></ref>
<ref id="bibr39-1753425910393369"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salah</surname><given-names>N</given-names></name><name><surname>Miller</surname><given-names>NJ</given-names></name><name><surname>Paganga</surname><given-names>G</given-names></name><name><surname>Tijburg</surname><given-names>L</given-names></name><name><surname>Bolwell</surname><given-names>GP</given-names></name><name><surname>Rice-Evans</surname><given-names>C</given-names></name></person-group>. <article-title>Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants</article-title>. <source>Arch Biochem Biophys</source> <year>1995</year>; <volume>322</volume>: <fpage>339</fpage>–<lpage>346</lpage>.</citation></ref>
<ref id="bibr40-1753425910393369"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Zamora</surname><given-names>R</given-names></name><name><surname>Zuckerbraun</surname><given-names>B</given-names></name><name><surname>Billiar</surname><given-names>TR</given-names></name></person-group>. <article-title>Role of nitric oxide in liver injury</article-title>. <source>Curr Mol Med</source> <year>2003</year>; <volume>3</volume>: <fpage>519</fpage>–<lpage>526</lpage>.</citation></ref>
<ref id="bibr41-1753425910393369"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laskin</surname><given-names>DL</given-names></name><name><surname>Rodriguez del Valle</surname><given-names>M</given-names></name><name><surname>Heck</surname><given-names>DE</given-names></name><etal/></person-group>. <article-title>Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression</article-title>. <source>Hepatology</source> <year>1995</year>; <volume>22</volume>: <fpage>223</fpage>–<lpage>234</lpage>.</citation></ref>
<ref id="bibr42-1753425910393369"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matata</surname><given-names>BM</given-names></name><name><surname>Galinanes</surname><given-names>M</given-names></name></person-group>. <article-title>Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappa B DNA binding activity</article-title>. <source>J Biol Chem</source> <year>2002</year>; <volume>277</volume>: <fpage>2330</fpage>–<lpage>2335</lpage>.</citation></ref>
<ref id="bibr43-1753425910393369"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Go’ke</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression</article-title>. <source>J Exp Med</source> <year>2000</year>; <volume>191</volume>: <fpage>1095</fpage>–<lpage>1104</lpage>.</citation></ref>
<ref id="bibr44-1753425910393369"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chanana</surname><given-names>V</given-names></name><name><surname>Majumdar</surname><given-names>S</given-names></name><name><surname>Rishi</surname><given-names>P</given-names></name></person-group>. <article-title>Tumour necrosis factor-α mediated apoptosis in murine macrophages by <italic>Salmonella enterica</italic> serovar Typhi under oxidative stress</article-title>. <source>FEMS Immunol Med Microbiol</source> <year>2006</year>; <volume>47</volume>: <fpage>278</fpage>–<lpage>2786</lpage>.</citation></ref>
<ref id="bibr45-1753425910393369"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rishi</surname><given-names>P</given-names></name><name><surname>Mavi</surname><given-names>SK</given-names></name><name><surname>Bharrhan</surname><given-names>S</given-names></name><name><surname>Shukla</surname><given-names>G</given-names></name><name><surname>Tewari</surname><given-names>R</given-names></name></person-group>. <article-title>Protective efficacy of probiotic alone or in conjunction with a prebiotic in <italic>Salmonella</italic>-induced liver damage</article-title>. <source>FEMS Microbiol Ecol</source> <year>2009</year>; <volume>69</volume>: <fpage>222</fpage>–<lpage>230</lpage>.</citation></ref>
<ref id="bibr46-1753425910393369"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Nam</surname><given-names>SY</given-names></name><etal/></person-group>. <article-title>The inhibitory effect of quercitrin gallate on iNOS expression induced by lipopolysaccharide in Balb/c mice</article-title>. <source>J Vet Sci</source> <year>2008</year>; <volume>9</volume>: <fpage>267</fpage>–<lpage>272</lpage>.</citation></ref>
<ref id="bibr47-1753425910393369"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>JK</given-names></name></person-group>. <article-title>(–)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB</article-title>. <source>Mol Pharmacol</source> <year>1997</year>; <volume>52</volume>: <fpage>465</fpage>–<lpage>472</lpage>.</citation></ref>
<ref id="bibr48-1753425910393369"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>MM</given-names></name><name><surname>Chakravortty</surname><given-names>D</given-names></name><name><surname>Sugiyama</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells</article-title>. <source>J Endotoxin Res</source> <year>2001</year>; <volume>7</volume>: <fpage>431</fpage>–<lpage>438</lpage>.</citation></ref>
<ref id="bibr49-1753425910393369"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BH</given-names></name><name><surname>Cho</surname><given-names>SM</given-names></name><name><surname>Reddy</surname><given-names>AM</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Min</surname><given-names>KR</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name></person-group>. <article-title>Down-regulatory effect of quercitrin gallate on nuclear factor-κB-dependent inducible nitric oxide synthase expression in lipopolysaccharide-stimulated macrophages RAW 264.7</article-title>. <source>Biochem Pharmacol</source> <year>2005</year>; <volume>69</volume>: <fpage>1577</fpage>–<lpage>1583</lpage>.</citation></ref>
</ref-list>
</back>
</article>